Slide
Session 59: HIV-1 in Women/Pediatrics
509 Immunoreconstitution
and Viral Dynamics in HIV-1-Infected Infants under Highly Active Antiretroviral
Therapy.
510 Early
HIVenvGene Evolution in Perinatally Infected Infants Predicts the Rate of Disease
Progression.
511 Effect
of Recent Thymic Emigrants on Progression of HIV-1 Disease Among Children with
Perinatal HIV-1 Infection.
512 Maternal
Factors Influencing Pediatric HIV Disease Progression.
513 Gender
Differences in Immunologic and Virologic Markers in Children Born to Women Infected
by Human Immunodeficiency Virus (HIV).
514 10-Year
Follow-Up of Somatic Growth in Children Born to Women Infected by Human Immunodeficiency
Virus (HIV).
515 Impact
of Protease Inhibitor (PI)-Containing Combination Antiretroviral Therapies on
Height and Weight Growth in HIV-Infected Children.
516 Selection
of Nevirapine Resistance (NVPR) Mutations in Ugandan Women
and Infants Receiving NVP Prophylaxis To Prevent HIV-1 Vertical Transmission
(HIVNET-012).
517 Perinatal
Transmission of HIV-1 from Pregnant Women with RNA Viral Load Less than 1000
Copies/ml.
518 Impact
of Highly Active Antiretroviral Therapy (HAART) on Cervical Intraepithelial
Neoplasia (CIN) in HIV-Seropositive Women.